InventionMed S.A. (WSE:INM)
Poland · Delayed Price · Currency is PLN 0.1700
+0.0005 (0.29%)
At close: Aug 12, 2025
InventionMed Revenue
InventionMed had revenue of 199.51K PLN in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to 477.27K, up 78,787.77% year-over-year. In the year 2024, InventionMed had annual revenue of 277.76K with 45,810.74% growth.
Revenue (ttm)
477.27K
Revenue Growth
+78,787.77%
P/S Ratio
71.81
Revenue / Employee
68.18K
Employees
5
Market Cap
34.27M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 277.76K | 277.16K | 45,810.74% |
| Dec 31, 2023 | 605.00 | -3.46K | -85.12% |
| Dec 31, 2022 | 4.07K | -6.39K | -61.10% |
| Dec 31, 2021 | 10.45K | 5.25K | 100.96% |
| Dec 31, 2020 | 5.20K | -35.80K | -87.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Diagnostyka | 2.06B |
| NEUCA | 12.82B |
| Voxel | 556.98M |
| Synektik Spólka Akcyjna | 623.20M |
| Celon Pharma | 215.11M |
| Ryvu Therapeutics | 97.57M |
| Selvita | 359.79M |
| Centrum Medyczne ENEL-MED | 762.83M |